Cargando…
Potential biomarkers and therapeutic targets in juvenile spondyloarthritis patients
Autores principales: | Lamot, Lovro, Vidović, Mandica, Perica, Marija, Bukovac, Lana Tambić, Gotovac, Kristina, Borovečki, Fran, Harjaček, Miroslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184235/ http://dx.doi.org/10.1186/1546-0096-12-S1-P44 |
Ejemplares similares
-
Aberrant Expression of Shared Master-Key Genes Contributes to the Immunopathogenesis in Patients with Juvenile Spondyloarthritis
por: Lamot, Lovro, et al.
Publicado: (2014) -
Single nucleotide polymorphism of NLRP3 (Q705K) In juvenile spondyloarthritis and oligo/ polyarticular juvenile idiopathic arthritis
por: Perica, Marija, et al.
Publicado: (2014) -
Monitoring the efficacy of intraarticular infliximab by musculoskeletal ultrasound and juvenile arthritis disease acitivty score (JADAS) in JIA patients – single center experience
por: Vidovic, Mandica, et al.
Publicado: (2014) -
Virtual 3D/4D vascular sonobiopsy of the knee joint: validation of the method in the JIA patients treated with ia infliximab or triamcinolone hexacetonide
por: Harjacek, Miroslav, et al.
Publicado: (2014) -
PReS-FINAL-2151: HLA B27/B7, TLR-4, NLRP3, CXCR4 AND PTPN12: the shared genetic master-key genes leading to development of undifferentiated spondyloarthritis/era in children
por: Lamot, L, et al.
Publicado: (2013)